P/E at 60.28 vs Industry's 59.55: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Reflecting Sector Leadership?

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 60.28, slightly above the hospital industry average of 59.55. This premium, though not extreme, suggests that investors are willing to pay a higher multiple for the company’s earnings relative to its peers. Given the company’s large-cap status with a market capitalisation of ₹1,18,219.74 crores, this valuation premium may reflect confidence in its market position and earnings stability. However, the narrow margin between the stock’s P/E and the industry average invites the question of whether this premium is justified by recent performance or if it signals a stretched valuation — previously rated Hold, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: Strong Long-Term Gains Amid Shorter-Term Volatility

Examining returns over multiple horizons reveals a stock that has consistently outperformed the broader market. Over one year, Apollo Hospitals gained 19.23%, contrasting sharply with the Sensex’s 7.78% loss. This outperformance extends to longer periods, with three-year returns at 70.63% versus the Sensex’s 20.32%, five-year returns at 153.77% against 44.63%, and a remarkable ten-year return of 481.84% compared to 181.18% for the Sensex. Such sustained gains underscore the company’s resilience and growth trajectory over the past decade.

However, the shorter-term picture is more mixed. The stock’s three-month return of 5.14% outpaces the Sensex’s decline of 7.59%, but the one-week performance shows a 2.18% loss, slightly worse than the Sensex’s 1.80% drop. The one-month return of 7.63% is positive and well ahead of the Sensex’s negative 2.34%. This divergence between short-term dips and medium-term strength — is this a recovery or a dead-cat bounce? — highlights the stock’s recent volatility within an overall upward trend.

Moving Average Configuration: Signs of a Consolidation Phase

The technical setup for Apollo Hospitals reveals that the stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive medium- to long-term trend. However, it remains below its 5-day moving average, suggesting some near-term hesitation or profit-taking. This configuration often points to a consolidation phase where short-term momentum is cooling but the broader trend remains intact. The stock is also just 3.81% away from its 52-week high of ₹8,490.3, signalling proximity to recent peak levels.

Such a pattern can be interpreted as a pause before a potential continuation or a warning of a possible pullback — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Performance Context: Hospital Industry Shows Mixed Results

The hospital sector, to which Apollo Hospitals belongs, has experienced a varied performance landscape recently. While some companies in the sector have reported positive results, others have remained flat or declined. This mixed sector performance underscores the importance of company-specific factors in driving stock returns. The fact that Apollo Hospitals has outperformed the Sensex and maintained a premium valuation suggests it is viewed as a leader within its industry.

Rating Reassessment: Previously Hold, Now Under Review

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as Hold. The rating was reassessed on 11 May 2026, reflecting updated analysis of the company’s fundamentals, valuation, and technicals. While the current rating is not disclosed, the reassessment indicates a shift in the evaluation framework. The stock’s strong long-term returns and valuation premium are balanced by recent short-term volatility and a cautious technical setup — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: A Data-Driven View of Valuation and Momentum

The data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight premium to its industry peers, supported by strong long-term returns and a solid market capitalisation. The recent short-term performance shows some volatility, with the stock underperforming the Sensex over the past week but outperforming over three months and one year. The moving average configuration suggests a consolidation phase, with the stock positioned above key medium- and long-term averages but below the very short-term 5-day average.

This combination of valuation, performance, and technical signals creates a nuanced investment profile — what is the current rating for Apollo Hospitals Enterprise Ltd. after this reassessment?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →